Adipose-derived stem cells ameliorate erectile dysfunction after cavernous nerve cryoinjury

Area of Science:

• Regenerative Medicine
• Urology
• Stem Cell Therapy

Background:

• Erectile dysfunction (ED) is a frequent complication after prostate cancer cryotherapy.
• Cavernous nerve (CN) cryoinjury is a model for studying ED.
• Adipose-derived stem cells (ADSC) show potential in regenerative therapies.

Purpose of the Study:

• To evaluate the efficacy of ADSC in improving erectile function after CN cryoinjury in rats.
• To investigate the underlying mechanisms of ADSC treatment on erectile function.
• To assess the impact of ADSC on nerve regeneration and penile tissue repair.

Main Methods:

• Rats underwent bilateral CN cryoinjury followed by intracavernous (IC) injection of EdU-labeled ADSC.
• Erectile function was assessed before tissue harvest.
• Penile tissues were analyzed for histology, apoptosis (cleaved caspase 3), and neurotrophic factor levels (NGF, VEGF, Neurturin) at 1 and 4 weeks post-treatment.

Main Results:

• ADSC treatment significantly improved erectile function.
• Enhanced regeneration of nNOS-positive nerves and recovery of cavernous tissue were observed.
• ADSC administration reduced apoptosis and increased levels of neurotrophic factors (NGF, VEGF, Neurturin).
• Labeled ADSC were found near penile vessels and nerves one week post-injection.

Conclusions:

• IC injection of ADSC effectively restores erectile function following CN cryoinjury in a rat model.
• The therapeutic effects are likely mediated by increased neurotrophic factors, promoting nerve regeneration and tissue repair.
• ADSC represent a promising therapeutic strategy for post-cryoinjury erectile dysfunction.